Lineage Cell Therapeutics Inc. - Capital/Financing Update 2021

PROSPECTUS SUPPLEMENT (To Prospectuses dated March 19, 2021 and May 8, 2020)�� 8.5.2020 �- 19.3.2021 false


��' ��	2 380
.LINEAGE CELL THERAPEUTICS, INC
Corporation no: 876343	10834
- - -


	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	21/12/2021
	www.isa.gov.il			www.tase.co.il				Reference:	2021-02-182877	Time of broadcast: 13:59 13:59

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onPROSPECTUS SUPPLEMENT (To Prospectuses dated March 19, 2021 and May 8, 2020) �� 8.5.2020 �- 19.3.2021

424_isa.pdf



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: -1	Date of revision of form structure: 15/12/2021
Address: HARBOR BAY PARKWAY 1301 , ALAMEDA 94502 CALIFORNIA , U.S.A Tel: 5105213390 , Fax: 5105213389
E-mail address: [email protected] Company site: biotimeinc.com

Previous names of reporting entity: .BIOTIME, INC

Name of the Signatory: Gerzi Ilan Position of Signatory in the reporting corporation: Attorney/Legal Counsel Name of Employer Company: PEARL COHEN ZEDEK LATZER BARATZ
Address: Derech Menachem Begin 132 , Tel-Aviv 6702101 Telephone: 03-6073777 Facsimile: 03-6073778 E-mail: [email protected] 1
U.S.A

AI assistant